about
Gene signatures associated with drug resistance to irinotecan and oxaliplatin predict a poor prognosis in patients with colorectal cancerTime to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles.E47 and Id1 interplay in epithelial-mesenchymal transitionDifferential expression of ID4 and its association with TP53 mutation, SOX2, SOX4 and OCT-4 expression levels.Clinical implications of the quantitative detection of ID4 gene methylation in myelodysplastic syndrome.Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cellsInsights into phosphorylation-dependent mechanisms regulating USP1 protein stability during the cell cycle.Hypomethylation of DNA-binding inhibitor 4 serves as a potential biomarker in distinguishing acquired tamoxifen-refractory breast cancerQuantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic AnemiaIdentifying anti-cancer drug response related genes using an integrative analysis of transcriptomic and genomic variations with cell line-based drug perturbationsmiR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer.Id4 promotes cell proliferation in hepatocellular carcinoma.Inhibitor of differentiation 4 (ID4): From development to cancerEpigenetic regulation of ID4 in the determination of the BRCAness phenotype in breast cancer.The Id-protein family in developmental and cancer-associated pathways.Progastrin stimulates colonic cell proliferation via CCK2R- and β-arrestin-dependent suppression of BMP2.The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1.Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages.
P2860
Q33598237-1F881144-0235-44C5-B4F1-F40F7C9941DBQ34071483-D61DDFAD-4B6E-4CC3-91B9-A99ABF991C56Q34652699-555C6FA4-F5BA-4058-B588-C8513519D695Q34684614-37D8735B-BEDC-4861-AC1C-E6833021A50FQ35108501-AC1EF3B5-E949-4460-8BE9-BBF2695C5F75Q35553504-EEF99CB4-6226-4692-8B6A-E1E5F13F839FQ35737571-45EE6C5B-6B2B-43CC-B494-EC3C7EDE8805Q36095385-C3111200-18C6-463A-9F87-FA54F8C2E56CQ36477232-FC5CA602-0A1B-466D-B722-96CE4B505CC2Q36962620-A89F6D63-F0B5-4C03-98D6-360961C1D281Q37521015-5D5F0C89-C73D-4D42-9E1B-EC6E62438FC2Q37618601-1482B706-284B-4370-84E1-59C7C11161F9Q38289940-F21292FD-9156-4F98-80C2-2C2901FD2D6FQ38938253-909D0ACC-1B26-4CB8-B9F9-11CB9F75E855Q39103288-3C8FFB20-F3AA-4BAC-AE28-C997CD0FDAB4Q41821291-E1DC4387-5184-4AAE-8974-5880F4615E97Q42511555-8C44D5D9-5F8D-4688-9C3E-4392F82492C6Q55300491-F1B1BB1D-5A04-42B4-9CCD-9D131C6C5362
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
ID4: a new player in the cancer arena.
@en
type
label
ID4: a new player in the cancer arena.
@en
prefLabel
ID4: a new player in the cancer arena.
@en
P2093
P2860
P1433
P1476
ID4: a new player in the cancer arena.
@en
P2093
Federica Ganci
Giovanni Blandino
Giulia Fontemaggi
Sabrina Strano
Stefania Dell'Orso
P2860
P356
10.18632/ONCOTARGET.100511
P407
P577
2010-05-01T00:00:00Z